Upload Avatar (500 x 500)
Yongshun Chen
Medical School
Wuhan University
Hubei
Language: English, Chinese
Digestive Oncology
Integrative Therapy
Radiosensitization
Cancer Therapy
Clinical Research
Targeted Therapy
Radiation Therapy
Oncology
Treatment Protocols
Clinical Outcomes
Areas of Focus
- Integrative therapy of digestive oncology
- Radiosensitization and cancer therapy
Work Experience
- 2000.08-2007.08 Resident and Attending Physician, Oncology, Zhengzhou People's Hospital
- 2010.08-2016.08 Associate Chief Physician, Zhengzhou University Affiliated Oncology Hospital
- 2013.07-2014.05 Postdoctoral Researcher, Peter MacCallum Cancer Center, Australia
- 2016.09-present Professor and Chief Physician, Oncology Center, Renmin Hospital of Wuhan University
Academic Background & Achievements
- 1995.09-2000.06 Bachelor of Clinical Medicine, Henan Medical University
- 2003.09-2006.06 Master of Pathology and Pathophysiology, Zhengzhou University
- 2007.09-2010.06 PhD in Oncology, West China School of Clinical Medicine, Sichuan University
- Hosted 8 national and provincial projects, published over 50 papers
Publications
- With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous carcinoma of the esophagus: a propensity score-matched analysis., Yongshun Chen, 2018
- Enhancing the Photodynamic Therapy Efficacy of Black Phosphorus Nanosheets by Covalently Grafting Fullerene C60., Yongshun Chen, 2020
- Buffer wards for the control of COVID-19 transmission in hospitals., Yongshun Chen, 2020
- Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation., Yongshun Chen, 2021
- Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: a propensity score matching and landmark analyses., Yongshun Chen, 2021
- Preoperative chemotherapy for limited-stage small cell carcinoma of the esophagus., Yongshun Chen, 2022
- Taming metabolic competition via glycolysis inhibition for safe and potent tumor immunotherapy., Yongshun Chen, 2022
- Evaluation of Concurrent Chemoradiotherapy in Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma., Yongshun Chen, 2022
- Circ_0011385 knockdown inhibits cell proliferation, migration and invasion, whereas promotes cell apoptosis by regulating miR-330-3p/MYO6 axis in colorectal cancer., Yongshun Chen, 2023
- Aspirin induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer., Yongshun Chen, 2023
- Radiotherapy plus camrelizumab and irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial., Yongshun Chen, 2023
- Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: a retrospective cohort study., Yongshun Chen, 2023
Awards
- 2015 Second Prize for Medical Technology Introduction for 'Cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal cancer'
- 2020 Second Prize for Scientific and Technological Progress in Hubei Province for 'Innovation and application of targeted and intelligent radiotherapy quality control system'
